Abstract:Background: The Bacillus Calmette-Guérin (BCG) vaccine, currently the sole authorized vaccine against tuberculosis (TB), demonstrates limited effectiveness in safeguarding adolescents and adults from active TB, even when administered as a booster with either BCG itself or heterologous vaccine candidates. To effectively control the persistent epidemic of adult TB, it is imperative to investigate the mechanisms responsible for the suboptimal efficacy of the BCG prime-boosting strategy against primary Mycobacterium tuberculosis (M.tb) infection. Methods: C57BL/6J mice were immunized with the BCG vaccine either once or twice, followed by analysis of lung tissue to assess changes in cytokine levels. Additionally, varying intervals between vaccinations and detection times were examined to study IL-10 expression across different organs. IL-10-expressing cells in the lungs, spleen, and lymph nodes were analyzed through FACS and intracellular cytokine staining (ICS). BCG-revaccinated IL-10-/- mutant mice were compared with wild-type mice to evaluate antigen-specific IgG antibody and T cell responses. Protection against M.tb aerosol challenge was evaluated in BCG-revaccinated mice, either untreated or treated with anti-IL-10R monoclonal antibody. Results: IL-10 was significantly upregulated in the lungs of BCG-revaccinated mice shortly after the booster immunization. IL-10 expression peaked in the lungs 3-6 weeks post-revaccination and was also detected in lymph nodes and spleen as early as 2 weeks following the booster dose, regardless of the intervals between the prime and booster vaccinations. The primary sources of IL-10 in these tissues were identified as macrophages and dendritic cells. Blocking IL-10 signaling in BCG-revaccinated mice-either by using IL-10-/- mutant mice or administering anti-IL-10R monoclonal antibody increased levels of antigen-specific IFN-γ+ or IL-2+ CD4+ T cells, enhanced central and effector memory CD4+ T cell responses, and provided better protection against aerosol infection with 300 CFUs of M.tb. Conclusion: Our findings are crucial for formulating effective immunization strategies related to the BCG vaccine and for developing efficacious adult TB vaccines.

Optimization of in Vitro Immunization Protocol to Produce Antigen Specific Human Monoclonal Antibody by Demonstrating the Role of IL-10

IL-10 Augments Antibody Production Inin VitroImmunized Lymphocytes by Inducing a Th2-Type Response and B Cell Maturation

Gene Therapy of Experimental Autoimmune Thyroiditis Mice by in Vivo Administration of Plasmid Dna Coding for Human Interleukin-10

Increasing a robust antigen-specific cytotoxic T lymphocyte response by FMDV DNA vaccination with IL-9 expressing construct.

Anti-Peptide Antibody Production Elicited by in Vitro Immunization of Human Peripheral Blood Mononuclear Cells

Tolerance induction via a B-cell delivered gene therapy-based protocol: optimization and role of the Ig scaffold.

IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

Establishment of Ovalbumin Immunotolerance Model in DO11.10 Mice

IL-10 Has A Distinct Immunoregulatory Effect on Naive and Active T Cell Subsets

In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines

Induction of tolerance by IL-10-treated dendritic cells.

IL-10 Dampens the Th1 and Tc Activation Through Modulating DC Functions in BCG Vaccination

Phosphorothioated Antisense Oligodeoxynucleotide Suppressing Interleukin-10 is a Safe and Potent Vaccine Adjuvant.

Paradoxical priming effects of IL-10 on cytokine production

IL-10 induces TGF-β secretion, TGF-β receptor II upregulation, and IgA secretion in B cells

Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFN-gamma over IL-4 responses

Early introduction of IL-10 weakens BCG revaccination's protection by suppressing CD4+Th1 cell responses

Basophils induce CD8 T cell IL-10 production (83.14)

A Soluble Antigen-Specific Factor from Cd4(+)Cd25(+) T Cells of Ova Tolerant Mice Inducing Ova-Specific Peripheral Tolerance Independently in Vivo

Modulation of Th1 and Th2 Cytokine Production with Imiquimod in the PBLN Cell Cultures from Ovalbumin-Sensitized Rats

Basophils induce CD8 T cell IL-10 production